Hello CRISPR Medicine News Readers

CRISPR Medicine Jobs is Coming Soon!

Did you see that we will launch the first targeted recruitment platform for CRISPR-related jobs later this month? Soon, prospective employers and job seekers from all over the world will be able to use this unique platform to find highly skilled scientists and exciting jobs within the CRISPR Medicine field!

Join Our Team!

The CRISPR Medicine field is growing, clinical trials are ongoing, and we now need to grow too, so that we can keep up with the news! We are therefore looking to add some talented and experienced freelance science writers to our team. Find out more about this here.

Catch Up With CRISPR COVID-19 Diagnostics

Companies and research groups all over the world have joined the fight against COVID-19, and as the pandemic continues, so too does the wave of innovative CRISPR-Cas diagnostics. Catch up on our CRISPR COVID-19 coverage in our latest post!

Your Missing Links Are Here!

Top Picks

• Kinetic profiling of Cas nucleases can help scientists to design safer and more efficient CRISPR experiments. Read about it in CRISPR Medicine News.
• In vivo CRISPR gene editing in memory CD8 T cells have been achieved for the first time by temporarily inhibiting the transcription factor p53 that otherwise precludes Cas9-mediated gene disruption in this cell type.

Research

• Cancer researchers in Germany have received ERC funding for single-cell CRISPR studies to unravel the biological effects of DNA circularisation and reintegration in an attempt to understand the role of extrachromosomal DNA in cancer development. See press release from Charité - Universitätsmedizin Berlin.
• Russian scientists have studied the CRISPR Type III system of extreme thermophilic bacteria and unravelled how they recognise and destroy invading bacteriophages.
• Efficient animal breeding often requires a surplus of a single sex. This has been achieved in a mouse model where CRISPR is used to generate all-male litters by creating a synthetic female-lethal bicomponent system.
• In case you missed it, researchers at McGill University, Canada use CRISPR to remove the gene that confers resistance to ionising radiation in glioblastoma.

Clinical Trials

• Caribou Biosciences has received FDA clearance to start Phase I clinical trials for its off-the-shelf allogenic anti-CD19 CAR-T therapy for patients with relapsed/refractory B cell non-Hodgkin lymphoma. The treatment uses CRISPR to deplete PD-1 from CAR-T cells.

Industry

• The market research firm Industry Research just published a comprehensive report analysing the global CRISPR business opportunities, including niche markets, potential risks and comprehensive competitive strategy analysis.
• Another global CRISPR market report from Kenneth Research takes a more research-oriented approach by breaking up the business opportunities into specific applications like genome editing, genetic engineering, gene library, CRISPR plasmid, human stem cells, genetically modified organism, and cell line engineering.
• Sherlock Biosciences, a CRISPR diagnostics company, has appointed Dr Martin Madaus as Chief Operations Officer. Dr Madaus has nearly 30 years of industry experience leading diagnostics companies across all stages of development through commercialisation.

COVID-19

• Read about how Mammoth Biosciences developed its CRISPR-based COVID19 Diagnostic DETECTR. The story features CTO Janice Chen, who says: »We want to shift the paradigm of ‘I need to go to the doctor’s office for testing’ to the consumer’s home.«
• Learn more about next-generation diagnostics in this interview with Sherlock Biosciences CTO Will Blake and GlobalData medical analyst Brian Hicks.

Delivery

• A novel gene therapy delivery technology by PYC Therapeutics explores lipid nanoparticles for intracellular delivery of a range of gene therapy cargoes.
• Genetic engineering, no virus required. Companies are optimising nonviral methods for delivering DNA and RNA gene-editing tools.

Education

• An educational tool kit the size of a lunch box contains everything the next generation of genetic scientists and technicians need to master the CRISPR gene-editing technology.

Conferences and Webinars

• An upcoming online and physical symposium New genome editing technologies for medicine and agriculture - implications for the society is taking place at Lund University on 13 October 2020.
• CRISPRcon 2020 is a series of 10 webinars covering five themes during September and October. The next webinar is scheduled for 15 September and is a panel discussion on how gene editing-focused approaches may exacerbate or address racial health disparities in the era of COVID-19.
• A previous panel discussion at CRISPRcon 2020 addressed how journalists are shaping society’s values and views on gene editing through their choices of what stories to tell, and how to frame them. Watch it on YouTube here.

Thank you for now - more great reads are on the way!

And if you have questions or suggestions, you can reach out to us directly at editor@crisprmedicinenews.com.

We love hearing from readers!

Happy Reading!

Gorm

P.S. You can follow CRISPR Medicine News on Twitter and LinkedIn. If someone forwarded this email to you, you could sign up for our newsletter yourself here.